Richard Maziarz: Where We Are and Where Cell Therapy Is Going?
Richard Maziarz, Medical Director, Blood and Marrow Transplant, Cellular Therapy Program at Oregon Health and Science University, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Transplantation and Cellular Therapy, adding:
”Where we are, where we are going?
That was the message delivered during the opening session at the Tandem meetings 2026: A summary of the CIBMTR/EBMT/ASTCT collaborative has just been published.
The work ahead is daunting but the future looks bright for cell therapy clinical care delivery.”
Title: Challenges with expansion of cell and gene therapy: A call for system-level action
Authors: Jeffery J. Auletta, Alvaro Urbano-Ispizua, Richard T. Maziarz, Anna Sureda, Sumithra Vasu, David L. Porter
Stay updated wih Hemostasis Today.
-
Oct 6, 2026, 16:03Professor Csongor Kiss Receives the Kálmán Laki Prize – Hungarian Society of Thrombosis and Haemostasis
-
Oct 6, 2026, 15:52Mark Kheifets: A Massive Stent Thrombosis Requiring Aspiration Thrombectomy
-
Oct 6, 2026, 15:40Joseph Aslan։ Targeting Mitochondrial Permeability Transition To Reduce Platelet Thrombogenicity
-
Oct 6, 2026, 15:36Nominations Open for ISTH Outstanding Mentor Awards – ISTH
-
Oct 6, 2026, 15:17Walaa Obaid: How Warfarin Went From Poison To Medicine
-
Oct 6, 2026, 15:16Nathan Hutchinson-Jones: Pharmacist-Led Care Optimises Cancer-Associated Thrombosis
-
Oct 6, 2026, 14:46Counting Down to WTD With a Focus on Thrombosis in Pregnancy
-
Oct 6, 2026, 14:29Jorge Enrique: Navigating Anticoagulation in Pregnancy With a Prosthetic Heart Valve
-
Oct 6, 2026, 14:20Hassan Abdelhak: Understanding How LVADs Support the Failing Heart